Notification of cessation of securities - RAD

Oct 1, 2026 at 2:21 AM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Oct 1, 2026 at 2:21 AM EDT · 5 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-rad-1

Release

Appendix 3H - Notification of cessation of securitiesAppendix 3H - Notification of cessation of securities1 / 5Announcement SummaryEntity nameRADIOPHARM THERANOSTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementThursday October 01, 2026Details of +securities that have ceasedASX...

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Change of Director's Interest Notice (RC)Oct 1
Appendix 4G and Corporate Governance StatementSep 30
Annual Report and Form 20-FSep 30
Change of Director's Interest Notices x 4Sep 22
Notification regarding unquoted securities - RADSep 16

Later from Radiopharm Theranostics

RAD Completes Meeting with US FDA for Development of RAD101Oct 4
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101Oct 5
Non-Compliance with Listing Rule 10.11Oct 11
Radiopharm receives $8M advance on FY26 R&D tax incentiveOct 26
Notice of Annual General Meeting/Proxy FormOct 26

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics